Antisera with anti-pan C3 receptor reactivity which block complement C3b, C3bi and C3d receptors.
Antisera directed at human C3 receptors were prepared by 2 different methods. In method I rabbits were immunized with EAC coated with C3 receptors of tonsil cells (AC3RS type I). In method II rabbits were immunized with insoluble aggregates of tonsil membrane constituents containing significant amounts of C3 receptors. After appropriate absorptions both types of AC3RS showed a selective reactivity with those cells known to express C3 receptors. With the EAC rosette inhibition test it is demonstrated that both types of AC3RS contain antibodies against the binding sites of C3b, C3bi and C3d receptors. The antibody titer was consistently higher in AC3RS of type II.
D000818:Animals; D001667:Binding, Competitive; D003176:Complement C3 / Q000378:metabolism*; D006801:Humans; D007104:Immune Adherence Reaction / Q000379:methods*; D007106:Immune Sera / Q000276:immunology / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D014066:Palatine Tonsil / Q000166:cytology / Q000378:metabolism; D011817:Rabbits; D011951:Receptors, Complement / Q000276:immunology; D012397:Rosette Formation; D013950:Thymus Gland / Q000378:metabolism
D003176:Complement C3; D007106:Immune Sera; D011951:Receptors, Complement